The aim of this study was to evaluate changes in men’s sexual function after percutaneous transluminal coronary angioplasty (PTCA) treatment for acute myocardial infarction (MI). Sixty men aged 18–70 ...

Re-restenosis after percutaneous transluminal coronary angioplasty (PTCA) for the treatment of in-stent restenosis is usually associated with very high recurrence rates (40% to 50%). Intracoronary ...

Objectives. To evaluate the efficacy of percutaneous transluminal coronary angioplasty (PTCA) for anastomotic stenosis after coronary artery bypass grafting (CABG) in patients with Kawasaki disease ...

Boston, MA - Results of the CADILLAC trial, showing stents to be superior to primary PTCA in acute MI (AMI) patients, have now been published in the New England Journal of Medicine. The Controlled ...

Percutaneous transluminal angioplasty (PCTA) is a surgical procedure to treat heart disease. It involves inserting a small balloon into the arteries to manage blockages or restore blood flow. A person ...

SINGAPORE, QT Vascular Ltd., together with its subsidiaries ("QT Vascular" or the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the ...

Geoffrey Hartzler, a key figure in the development of interventional cardiology in the United States, has died from cancer at the age of 65. He was one of the first cardiologists to learn the ...

Next-generation balloon catheter offers enhanced deliverability and expanded options for treating coronary artery lesions NATICK, Mass., Boston Scientific Corporation announces CE Mark and European ...

SAN FRANCISCO--(BUSINESS WIRE)--Cordis Corporation today announced EMPIRA™ and EMPIRA™ NC RX PTCA Dilatation Catheters have received 510(k) regulatory clearance for the treatment of coronary artery ...

FDA Approves Boston Scientific's Apex TM PTCA Dilatation Catheter New design provides more options for treating patients with complex lesions NATICK, Mass., Nov. 10 ...